Natural Killer Cell Therapy Industry Research Report 2025

Summary

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

According to APO Research, The global Natural Killer Cell Therapy market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Natural Killer Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Natural Killer Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Natural Killer Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma and Nkarta Therapeutics and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Natural Killer Cell Therapy Segment by Company

Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Natural Killer Cell Therapy Segment by Type

NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy Segment by Application

Cancer
Gastrointestinal Diseases
Others
Natural Killer Cell Therapy Segment by Application

Cancer
Gastrointestinal Diseases
Others
Natural Killer Cell Therapy Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Natural Killer Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Natural Killer Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 NK Cell Therapies
2.2.3 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Cancer
2.3.3 Gastrointestinal Diseases
2.3.4 Others
2.4 Assumptions and Limitations
3 Natural Killer Cell Therapy Breakdown Data by Type
3.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2020-2025)
3.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031)
4 Natural Killer Cell Therapy Breakdown Data by Application
4.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2020-2025)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Natural Killer Cell Therapy Market Perspective (2020-2031)
5.2 Global Natural Killer Cell Therapy Growth Trends by Region
5.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2020-2025)
5.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2026-2031)
5.3 Natural Killer Cell Therapy Market Dynamics
5.3.1 Natural Killer Cell Therapy Industry Trends
5.3.2 Natural Killer Cell Therapy Market Drivers
5.3.3 Natural Killer Cell Therapy Market Challenges
5.3.4 Natural Killer Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Natural Killer Cell Therapy Players by Revenue
6.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2020-2025)
6.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2020-2025)
6.2 Global Natural Killer Cell Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Natural Killer Cell Therapy Head Office and Area Served
6.4 Global Natural Killer Cell Therapy Players, Product Type & Application
6.5 Global Natural Killer Cell Therapy Manufacturers Established Date
6.6 Global Natural Killer Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Natural Killer Cell Therapy Market Size (2020-2031)
7.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Natural Killer Cell Therapy Market Size by Country (2020-2025)
7.4 North America Natural Killer Cell Therapy Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Natural Killer Cell Therapy Market Size (2020-2031)
8.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Natural Killer Cell Therapy Market Size by Country (2020-2025)
8.4 Europe Natural Killer Cell Therapy Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2020-2031)
9.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2020-2025)
9.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Natural Killer Cell Therapy Market Size (2020-2031)
10.2 South America Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Natural Killer Cell Therapy Market Size by Country (2020-2025)
10.4 South America Natural Killer Cell Therapy Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2020-2031)
11.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2020-2025)
11.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Nektar Therapeutics
12.1.1 Nektar Therapeutics Company Information
12.1.2 Nektar Therapeutics Business Overview
12.1.3 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.1.4 Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
12.1.5 Nektar Therapeutics Recent Developments
12.2 Innate Pharma SA
12.2.1 Innate Pharma SA Company Information
12.2.2 Innate Pharma SA Business Overview
12.2.3 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.2.4 Innate Pharma SA Natural Killer Cell Therapy Product Portfolio
12.2.5 Innate Pharma SA Recent Developments
12.3 Affimed
12.3.1 Affimed Company Information
12.3.2 Affimed Business Overview
12.3.3 Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.3.4 Affimed Natural Killer Cell Therapy Product Portfolio
12.3.5 Affimed Recent Developments
12.4 Chipscreen Biosciences
12.4.1 Chipscreen Biosciences Company Information
12.4.2 Chipscreen Biosciences Business Overview
12.4.3 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
12.4.5 Chipscreen Biosciences Recent Developments
12.5 Glycostem Therapeutics
12.5.1 Glycostem Therapeutics Company Information
12.5.2 Glycostem Therapeutics Business Overview
12.5.3 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
12.5.5 Glycostem Therapeutics Recent Developments
12.6 Fate Therapeutics
12.6.1 Fate Therapeutics Company Information
12.6.2 Fate Therapeutics Business Overview
12.6.3 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.6.4 Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
12.6.5 Fate Therapeutics Recent Developments
12.7 Dragonfly Therapeutics
12.7.1 Dragonfly Therapeutics Company Information
12.7.2 Dragonfly Therapeutics Business Overview
12.7.3 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
12.7.5 Dragonfly Therapeutics Recent Developments
12.8 Kiadis Pharma
12.8.1 Kiadis Pharma Company Information
12.8.2 Kiadis Pharma Business Overview
12.8.3 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.8.4 Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
12.8.5 Kiadis Pharma Recent Developments
12.9 Nkarta Therapeutics
12.9.1 Nkarta Therapeutics Company Information
12.9.2 Nkarta Therapeutics Business Overview
12.9.3 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
12.9.5 Nkarta Therapeutics Recent Developments
12.10 NantKwest
12.10.1 NantKwest Company Information
12.10.2 NantKwest Business Overview
12.10.3 NantKwest Revenue in Natural Killer Cell Therapy Business (2020-2025)
12.10.4 NantKwest Natural Killer Cell Therapy Product Portfolio
12.10.5 NantKwest Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings